Denali Therapeutics
DNLI
DNLI
67 hedge funds and large institutions have $949M invested in Denali Therapeutics in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
21% less capital invested
Capital invested by funds: $1.2B → $949M (-$252M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
94% less call options, than puts
Call options by funds: $12K | Put options by funds: $191K
Holders
67
Holding in Top 10
3
Calls
$12K
Puts
$191K
Top Buyers
| 1 | +$31M | |
| 2 | +$5.36M | |
| 3 | +$4.29M | |
| 4 |
Millennium Management
New York
|
+$2.62M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.44M |
Top Sellers
| 1 | -$22.9M | |
| 2 | -$6.4M | |
| 3 | -$5.23M | |
| 4 |
BM
Bridger Management
New York
|
-$5.05M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$2.33M |